Title & Disclosure
Reshaping the paradigm: Implications of recent clinical advances in the diagnosis and treatment of neuromyelitis optica spectrum disorder
This activity is an independently supported Satellite Symposium, not included in the MSVirtual2020 accredited program. CME certification is jointly provided by the Consortium of Multiple Sclerosis Centers (CMSC) and Efficient LLC., and supported by an educational grant from Genentech, a member of the Roche Group.
Brian Weinshenker, Mayo Clinic
Jerome de Seze, Strasbourg University Hospital
Benjamin Greenberg, University of Texas Southwestern Medical Center